Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation
Conditions: Pediatric Kidney Disease Interventions: Drug: Envarsus ®; Drug: Prograf Sponsors: University Hospital, Essen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
Advancing Transplantation Outcomes in Children
Conditions: Kidney Transplant Interventions: Drug: Sirolimus; Biological: Belatacept; Drug: Mycophenolate Mofetil; Drug: Tacrolimus (Group1); Drug: Anti-Thymocyte Globulin (ATG); Drug: Tacrolimus (Group 2) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
CAR-T Cell Therapy for Desensitization in Kidney Transplantation
Conditions: Kidney Transplant; Kidney Failure; Highly Sensitized Interventions: Drug: Cyclophosphamide; Biological: CART-BCMA; Biological: huCART19; Drug: Fludarabine Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); University of Pennsylvania Clinical Cell and Vaccine Production Facility (CVPF) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
Prospective, Randomized Controlled Trial to Investigate the Impact of AI on Shared Decision Making in Post-kidney Transplant Care
Conditions: Kidney Transplant Failure Interventions: Other: AI-based risk prediction for kidney graft loss Sponsors: Charite University, Berlin, Germany Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials
Proteinuria and Renal Perfusion in Renal Transplant Recipients
Conditions: Pre-kidney Transplant; Living Donor Kidney Transplantation; Renal Perfusion; End Stage Renal Disease Sponsors: University of Erlangen-N ürnberg Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2023 Category: Research Source Type: clinical trials
MYREPTIC-N ® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
Condition: Kidney Transplant Interventions: Drug: Myreptic-N Tablet; Drug: Mycophenolate mofetil Tablet/Capsule Sponsor: Chong Kun Dang Pharmaceutical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Development of Antibodies Against Transplant Kidney After Infection
Conditions: Acute Infection; Kidney Failure Intervention: Diagnostic Test: Level of antibodies Sponsor: University Hospital Ostrava Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 15, 2023 Category: Research Source Type: clinical trials
